| Metric | შპს საფ ფარმა | შპს Europharma Georgia ევროფარმა ჯორჯია |
|---|---|---|
| Growth | ||
| Revenue | ₾6.4m₾6.5m | ₾6.4m₾5.4m |
| Revenue growth | -1.3% | 19.8% |
| Profitability | ||
| EBITDA | ₾1.4m₾1.2m | ₾651k₾577k |
| EBITDA margin | 22.5%18.4% | 10.2%10.8% |
| Net profit | ₾1.5m₾1.1m | ₾643k₾577k |
| Net margin | 23.0%17.7% | 10.0%10.8% |
| Balance sheet | ||
| Total assets | ₾5.3m₾5.4m | ₾5.1m₾4.9m |
| Total equity | ₾2.7m₾1.2m | ₾3.1m₾2.2m |
| ROE | 54.6%93.9% | 20.6%26.4% |